VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Myricx Bio

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 78 out of 100

Developing the first class of ADCs based on NMT inhibition to treat cancer

  • Biotech & therapeutics
Business model
B2B
Legal name
Myricx Pharma Limited
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Developing a completely novel class of payloads for antibody drug conjugates (ADCs), based on inhibitors of the enzymes, N-myristoyltransferases (NMT) for the treatment of cancer.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy